Biomarker definitions and their applications
暂无分享,去创建一个
[1] Peter Sandercock,et al. Interpretation of the evidence for the efficacy and safety of statin therapy , 2016, The Lancet.
[2] Michael E. Miller,et al. Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.
[3] R. Califf,et al. Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions. , 2016, JAMA.
[4] Barry S. Coller,et al. Traversing the Valley of Death: A Guide to Assessing Prospects for Translational Success , 2009, Science Translational Medicine.
[5] P. F. Kauff. Group , 2000, Elegant Design.
[6] T. Insel. Digital Phenotyping: Technology for a New Science of Behavior. , 2017, JAMA.
[7] Gary Gintant,et al. Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium. , 2014, American heart journal.
[8] N. Cook. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.
[9] Michael E. Miller,et al. The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. , 2007, The American journal of cardiology.
[10] C. Lam,et al. Correlation of the New York Heart Association Classification and the 6‐Minute Walk Distance: A Systematic Review , 2015, Clinical cardiology.
[11] Sidney C. Smith,et al. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2016, Journal of the American College of Cardiology.
[12] Thomas R. Fleming,et al. Surrogate Endpoints in Clinical Trials , 1996 .
[13] R. Prentice. Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.
[14] F. Sundler,et al. The mouse trap. , 1997, Trends in pharmacological sciences.
[15] Joseph Loscalzo,et al. Precision medicine in cardiology , 2016, Nature Reviews Cardiology.
[16] Zane T. Macfarlane,et al. Validation of the Instant Blood Pressure Smartphone App. , 2016, JAMA Internal Medicine.
[17] Jackson T. Wright,et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. , 2016, The New England journal of medicine.
[18] Michael J Pencina,et al. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models , 2012, Statistics in medicine.
[19] Joseph Loscalzo,et al. Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine , 2012, Wiley interdisciplinary reviews. Systems biology and medicine.